Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 263

The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.

Nodular regenerative hyperplasia: Not all nodules are created equal

Open access
Reshamwala, Preeti A., Kleiner, David E., Heller, Theo · 2006 · Hepatology

Abstract

Nodular regenerative hyperplasia (NRH) of the liver is an uncommon condition characterized by the diffuse transformation of normal hepatic parenchyma into small, regenerative nodules with little to no fibrosis. A classification system proposed by Wanless in 19901 provided histological criteria for the diagnosis of NRH. These included the presence of hepatocellular nodules less than 3 mm in diameter that were not surrounded by fibrosis (nodules graded 0-3+ based on the extent of nodularity noted through all fields of the biopsy), and the presence of fibrous septa (graded 0-3). Biopsy specimens that met the criteria of 3+ nodularity and 0-1 fibrous septa were classified as nodular regenerative hyperplasia. NRH has been reported to occur in association with other systemic diseases, including rheumatologic disorders, vascular disorders, and myeloproliferative disorders, as well as certain drugs.1-10 Nodular regenerative hyperplasia may have a prolonged asymptomatic course unless it is complicated by portal hypertension and its sequelae, including variceal bleeding, ascites, and splenomegaly. In this article, the epidemiology, histology, differential diagnosis, and theories of etiology of NRH are reviewed. The diagnosis and treatment of nodular regenerative hyperplasia are also presented. NRH, nodular regenerative hyperplasia. Nodular regenerative hyperplasia of the liver was first described as "miliary hepatocellular adenomatatosis" by Ranstrom in 195311 in a patient with rheumatoid arthritis, neutropenia, and splenomegaly (Felty's syndrome). This lesion was subsequently termed nodular regenerative hyperplasia by Steiner,12 who described regenerative liver nodules in a patient with congestive heart failure and tuberculosis. Several cases have since been reported in the literature, and most have been associated with long-standing systemic diseases before clinical evidence of liver disease was detected. These associations are detailed in Table 1. A large study of 2,500 consecutive autopsies by Wanless in 19901 revealed that NRH was present in 64 patients (2.6%). Of these 64 cases, the majority were associated with systemic disorders. Wanless also noted that NRH was diagnosed in 5.3% of patients who were over 80 years of age at death. This prevalence was more than 7-fold higher when compared with patients who were under 60 years of age at death, likely reflecting the higher prevalence of systemic disease in an elderly population. Nevertheless, more than 20 cases of NRH have also been described in children,13, 14 and two cases have been reported in fetal liver.15 NRH affects both males and females equally. There have been three familial cases of nodular regenerative hyperplasia reported in the literature.16 On gross examination of the liver, the normally homogenous hepatic parenchyma shows a diffuse transformation into nodules of 1-3 mm in size. Unlike cirrhosis, there is no fibrosis separating nodules—each nodule presses directly against its neighbor. Although nodules greater than 15 mm have been described, these are frequently revealed to be composed of smaller nodules when examined microscopically.1, 17 The hepatocytes within the nodule are arranged in plates that are more than 1 cell thick. These cells may be enlarged and have hypertrophic nuclei. Between individual nodules, the hepatocytes are small and atrophic and are pressed together into thin, parallel plates. This compression is best visualized using a reticulin stain and may be associated with sinusoidal dilation and slitlike central veins. Immunohistochemical staining for alpha-1-antitrypsin has also been shown to be increased in the periportal areas of liver biopsies from NRH patients when compared to controls.18 This finding may be helpful in the histological evaluation of difficult cases. Whereas the larger portal veins may be widely patent, portal venous structures in smaller radicals may be absent or occluded. Fibrosis typical of chronic liver disease is usually not present, although there may be some degree of periportal fibrosis or perisinusoidal fibrosis. The latter is frequently associated with the atrophic areas. Very thin fibrous septation may be seen between the hepatic lobules. Central veins may show veno-occlusive changes or may be compressed into narrowed slits. Sinusoidal dilation may be seen in areas of hepatocellular atrophy. There is usually little or no inflammation or cholestasis, and normal bile ducts and arteries can be easily identified. These features are illustrated in Fig. 1. (A) Gross photograph of a resected specimen showing NRH. The liver parenchyma is diffusely transformed into nodules approximately 1 mm in size. There is a superficial resemblance to cirrhosis; however, the nodules are not separated by fibrosis. (B) Low magnification examination shows vague nodularity on routine staining, here enhanced by congestion in areas of atrophy between the nodules (hematoxylin-eosin; original magnification ×4). (C) Staining for col

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/hep.21258

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 263

Metadata

Authors
Reshamwala, P. A., Kleiner, D. E., & Heller, T.
Venue
Hepatology
Published
2006-07
Volume
44
Issue
1
Pages
7-14
ISSN
0270-9139 (ISSN-L)
OpenAlex
W1969356397
Cited by
263
References
21
FWCI
8.14
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.